AZD7451 for Recurrent Gliomas

NCT01468324 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: AZD7451

Sponsor

National Cancer Institute (NCI)